Primary Immunodeficiency Therapeutics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, China, UK, Canada - Size and Forecast 2024-2028

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Disease Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market

• 2.2 Market characteristics
  • Market characteristics analysis

• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition

• 3.2 Market segment analysis
  • Market segments

• 3.3 Market size 2023

• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Primary Immunodeficiency Therapeutics Market 2018 - 2022
  • Historic Market Size - Data Table on Global Primary Immunodeficiency Therapeutics Market 2018 - 2022 ($ million)

• 4.2 Disease Type segment analysis 2018 - 2022
  • Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)

• 4.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)

• 4.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028

• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028

• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028

• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028

• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028

• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028

• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Disease Type

• 6.1 Market segments
  • Chart on Disease Type - Market share 2023-2028 (%)
  • Data Table on Disease Type - Market share 2023-2028 (%)

• 6.2 Comparison by Disease Type
  • Chart on Comparison by Disease Type
  • Data Table on Comparison by Disease Type

• 6.3 Antibody deficiency - Market size and forecast 2023-2028
  • Chart on Antibody deficiency - Market size and forecast 2023-2028 ($ million)
  • Data Table on Antibody deficiency - Market size and forecast 2023-2028 ($ million)
  • Chart on Antibody deficiency - Year-over-year growth 2023-2028 (%)
  • Data Table on Antibody deficiency - Year-over-year growth 2023-2028 (%)

• 6.4 Cellular immunodeficiency - Market size and forecast 2023-2028
  • Chart on Cellular immunodeficiency - Market size and forecast 2023-2028 ($ million)
  • Data Table on Cellular immunodeficiency - Market size and forecast 2023-2028 ($ million)
  • Chart on Cellular immunodeficiency - Year-over-year growth 2023-2028 (%)
  • Data Table on Cellular immunodeficiency - Year-over-year growth 2023-2028 (%)

• 6.5 Innate immune disorders - Market size and forecast 2023-2028
  • Chart on Innate immune disorders - Market size and forecast 2023-2028 ($ million)
  • Data Table on Innate immune disorders - Market size and forecast 2023-2028 ($ million)
  • Chart on Innate immune disorders - Year-over-year growth 2023-2028 (%)
  • Data Table on Innate immune disorders - Year-over-year growth 2023-2028 (%)

• 6.6 Market opportunity by Disease Type
  • Market opportunity by Disease Type ($ million)
  • Data Table on Market opportunity by Disease Type ($ million)

7 Customer Landscape

• 7.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

• 8.1 Geographic segmentation
  • Chart on Market share by geography 2023-2028 (%)
  • Data Table on Market share by geography 2023-2028 (%)

• 8.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison

• 8.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)

• 8.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)

• 8.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)

• 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

• 8.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)

• 8.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)

• 8.9 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)

• 8.10 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)

• 8.11 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)

• 8.12 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

• 9.1 Market drivers

• 9.2 Market challenges

• 9.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028

• 9.4 Market opportunities/restraints

10 Competitive Landscape

• 10.1 Overview

• 10.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation

• 10.3 Landscape disruption
  • Overview on factors of disruption

• 10.4 Industry risks
  • Impact of key risks on business

11 Competitive Analysis

• 11.1 Companies profiled
  • Companies covered

• 11.2 Market positioning of companies
  • Matrix on companies position and classification

• 11.3 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus

• 11.4 Bio Products Laboratory Ltd.
  • Bio Products Laboratory Ltd. - Overview
  • Bio Products Laboratory Ltd. - Product / Service
  • Bio Products Laboratory Ltd. - Key offerings

• 11.5 Biocon Ltd.
  • Biocon Ltd. - Overview
  • Biocon Ltd. - Business segments
  • Biocon Ltd. - Key offerings
  • Biocon Ltd. - Segment focus

• 11.6 Biotest AG
  • Biotest AG - Overview
  • Biotest AG - Business segments
  • Biotest AG - Key offerings
  • Biotest AG - Segment focus

• 11.7 CSL Ltd.
  • CSL Ltd. - Overview
  • CSL Ltd. - Business segments
  • CSL Ltd. - Key news
  • CSL Ltd. - Key offerings
  • CSL Ltd. - Segment focus

• 11.8 Grifols SA
  • Grifols SA - Overview
  • Grifols SA - Business segments
  • Grifols SA - Key news
  • Grifols SA - Key offerings
  • Grifols SA - Segment focus

• 11.9 Kedrion Spa
  • Kedrion Spa - Overview
  • Kedrion Spa - Product / Service
  • Kedrion Spa - Key offerings

• 11.10 Octapharma AG
  • Octapharma AG - Overview
  • Octapharma AG - Product / Service
  • Octapharma AG - Key offerings

• 11.11 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings

• 11.12 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings

12 Appendix

• 12.1 Scope of the report

• 12.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist

• 12.3 Currency conversion rates for US$
  • Currency conversion rates for US$

• 12.4 Research methodology
  • Research methodology

• 12.5 Data procurement
  • Information sources

• 12.6 Data validation
  • Data validation

• 12.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing

• 12.8 Data synthesis
  • Data synthesis

• 12.9 360 degree market analysis
  • 360 degree market analysis

• 12.10 List of abbreviations
  • List of abbreviations